Related Experiment Video

Updated: Jan 19, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.2K

[Surgical Treatment of Ischemic Cardiomyopathy: Current State of the Problem]

V M Shipulin1, A S Pryakhin2, S L Andreev2

  • 1Сardiology Research Institute, Tomsk National Research Medical Centre, Siberian State Medical University.

Kardiologiia
|September 22, 2019
PubMed

Insights

This review discusses surgical treatments for ischemic cardiomyopathy (ICM), covering pathophysiology, myocardial viability assessment, and right ventricular dysfunction. It analyzes limitations of the STICH trial for heart failure patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Research

Background:

  • Ischemic cardiomyopathy (ICM) presents complex challenges in surgical treatment.
  • Left ventricular remodeling is a key pathophysiological aspect in ICM patients.
  • Right ventricular dysfunction is a significant concern in the management of ICM.

Purpose of the Study:

  • To provide a comprehensive overview of the current state of surgical treatment for ICM.
  • To detail methods for assessing myocardial viability and their relevance in ICM.
  • To critically analyze the limitations of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.

Main Methods:

  • Review of current literature on surgical interventions for ICM.
  • Analysis of pathophysiological mechanisms including left ventricular remodeling.
  • Evaluation of diagnostic techniques for myocardial viability assessment.
  • Discussion of right ventricular function in ICM.
  • Critical appraisal of the STICH study's findings and limitations.

Main Results:

  • Surgical treatment options for ICM are diverse, with varying efficacy.
  • Myocardial viability assessment is crucial for patient selection in revascularization strategies.
  • Understanding ventricular remodeling aids in predicting outcomes.
  • The STICH trial provided valuable insights but also highlighted limitations in surgical indications for ICM.

Conclusions:

  • Optimal surgical management of ICM requires a multifaceted approach.
  • Further research is needed to refine patient selection and surgical techniques for ICM.
  • Addressing ventricular remodeling and dysfunction is key to improving outcomes in ICM patients.

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.9K
Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System08:01

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System

Published on: June 11, 2020

8.7K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
347
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
482
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
179
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
478
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
225